Kits Eyecare Ltd (KITS) Fair Value & Analysis
Consumer Cyclical · CA · Market cap C$463M
Fair value as of: Aug 13, 2026
From 24 valuation models · updated yesterday
Share price +4.7% over the past month.
A solid business, but screening 78% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (C$4.09). The favourable scenario is already priced in.
- Solid but not exceptional quality (68/100) and above fair value, neither a clear bargain nor a standout compounder.
- A fairly wide model range (C$2.20 to C$4.09) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
60‑month range C$2.02 – C$21.93 · fair‑value band C$2.20 – C$4.09 · the C$14.49 price screens above the C$3.15 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 13, 2026.
Analysis
Kits Eyecare Ltd (KITS) currently trades at C$14.49, while our model-based Fair Value estimate is C$3.15, implying the stock looks roughly 78.3% overvalued today. The Quality Score stands at 68/100 (solid quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, Kits Eyecare Ltd generated revenue of C$213M at a net margin of 1.6%. Revenue grew 23.3% year over year. It earns a return on equity of 5.3%. The balance sheet holds a net cash position of C$14.0M. Fundamentals as of Aug 13, 2026
Our scenario range runs from C$2.20 (bear case) to C$4.09 (bull case); at C$14.49, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 36% below its 52-week high and 37% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Cyclical peers we cover trades at -20% fair-value upside, at -78%, KITS screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 24 models by family
Widest divergence: Growth DCF (C$6.62) versus Asset-Based (C$1.23). Highest evidence: Growth DCF (80).
Notify me when KITS reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 69 · Market factors (momentum, volatility) 42
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Kits Eyecare Ltd. operates a digital eyecare platform in the United States and Canada. It offers progressive, polarized, and contact lenses, eyeglasses, and frames under the KITS brand, as well as distributes eyewear products of various brands.
Full company description
Kits Eyecare Ltd. operates a digital eyecare platform in the United States and Canada. It offers progressive, polarized, and contact lenses, eyeglasses, and frames under the KITS brand, as well as distributes eyewear products of various brands. The company operates a network of optical e-commerce websites, including KITS.com, KITS.ca, OptiContacts.com, and ContactsExpress.ca. Kits Eyecare Ltd. was founded in 2002 and is headquartered in Vancouver, Canada.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Kits Eyecare Ltd reported revenue of C$202M in FY2025 versus C$82.4M in FY2021, a compound +25.2%/yr. Reported net income was C$3.1M in FY2025.
KITS screens 78% overvalued. Compare with Alimentation Couche-Tard Inc →
Peer Group
Specialty Retail · 223 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Specialty Retail median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Insider activity: 45/100
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Specialty Retail stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Alimentation Couche-Tard Inc ATD | C$93.19 | C$75.00 | -20% |
| Casey's General Stores, Inc CASY | $839.03 | $398.90 | -52% |
| Williams-Sonoma, Inc WSM | $245.15 | $162.63 | -34% |
| Ulta Beauty, Inc ULTA | $531.89 | $475.40 | -11% |
| DICK'S Sporting Goods, Inc DKS | $202.66 | $181.10 | -11% |
| Best Buy Co BBY | $83.00 | $108.04 | +30% |
| China Tourism Group 601888 | ¥54.97 | ¥40.40 | -27% |
| Tractor Supply Company TSCO | $36.43 | $35.52 | -2% |
| Murphy USA Inc MUSA | $544.22 | $423.35 | -22% |
| Taiwan Mobile Co 3045 | 109.50 TWD | 80.98 TWD | -26% |
Compare Kits Eyecare Ltd with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Cyclical stocks →
Frequently asked questions
Is Kits Eyecare Ltd (KITS) overvalued or undervalued?
What is the fair value of KITS?
What is the quality score of KITS?
What is the revenue of Kits Eyecare Ltd (KITS)?
What is the net profit margin of KITS?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Kits Eyecare Ltd and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.